Healthcare News

SAN DIEGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today...

RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial results on...

Arcutis today announced that it will report its Q3 2026 financial results and provide a business update after the U.S. financial markets close on Nov 4.

ANNOUNCEMENT NO. 322 21 October 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 15 October 2026,...

MEDDELELSE NR. 322 21. oktober 2026 I henhold til kapitalmarkedslovens § 30 skal det hermed oplyses, at BlackRock, Inc. har meddelt ChemoMetec A/S, at BlackRock, Inc. den 15. oktober 2026 har...

RIYAD, Arabie saoudite, 21 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) s’appuie sur l’intelligence artificielle pour anticiper la demande au sein de...

RIAD, Saudi-Arabien, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSH) nutzt künstliche Intelligenz, um die Auslastung der Notaufnahme 24 Stunden im...

Cosentyx® (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory rheumatic disease with limited advanced treatment options2-6Approval...

PRESSRELEASE 2026-10-21 Kallelse till extra bolagsstämma i Arcoma Aktiebolag Aktieägarna i Arcoma Aktiebolag, org.nr 556410-8198, kallas härmed till extra bolagsstämma i Sergelkonferensen på Mäster...

BEIJING, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Michael Levitt and May-Britt Moser represent two distinct paths of scientific discovery. One traveled from Stanford to Beijing; the other joined remotely...